ClinicalTrials.gov
public full text
Public Domain
SOD1 Inhibition by Pyrimethamine in Familial Amyotrophic Lateral Sclerosis (ALS)
The objective of this study will be to evaluate the safety, tolerability and effect on SOD1 levels by pyrimethamine in patients with familial amyotrophic lateral sclerosis.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Phase Ⅰ/Ⅱa Study of SNUG01 in Adult Subjects With ALS#841713
- NF-κB Inhibition in Amyotrophic Lateral Sclerosis#832518
- Effect of Safinamide on Sleep Quality in Patients With Parkinson's Disease#1164027
- Amyotrophic Lateral Sclerosis: A Multicenter Retrospective Observational Registry#873107
- Tolerability and Efficacy of L-Serine in Patients With Amyotrophic Lateral Sclerosis (ALS)#1033121
Record · ID 1150965
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive